These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


335 related items for PubMed ID: 34809715

  • 1. Sevoflurane preconditioning promotes mesenchymal stem cells to relieve myocardial ischemia/reperfusion injury via TRPC6-induced angiogenesis.
    Yang J, Tang L, Zhang F, Yang T, Lu T, Sun K, Sun N, Ren J, Yan M.
    Stem Cell Res Ther; 2021 Nov 22; 12(1):584. PubMed ID: 34809715
    [Abstract] [Full Text] [Related]

  • 2. Preconditioning of mesenchymal stem cells by sevoflurane to improve their therapeutic potential.
    Sun X, Fang B, Zhao X, Zhang G, Ma H.
    PLoS One; 2014 Nov 22; 9(3):e90667. PubMed ID: 24599264
    [Abstract] [Full Text] [Related]

  • 3. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection.
    Herrmann JL, Wang Y, Abarbanell AM, Weil BR, Tan J, Meldrum DR.
    Shock; 2010 Jan 22; 33(1):24-30. PubMed ID: 19996917
    [Abstract] [Full Text] [Related]

  • 4. Effects of Sevoflurane Pretreatment on Myocardial Ischemia-Reperfusion Injury Through the Akt/Hypoxia-Inducible Factor 1-alpha (HIF-1α)/Vascular Endothelial Growth Factor (VEGF) Signaling Pathway.
    Dong J, Xu M, Zhang W, Che X.
    Med Sci Monit; 2019 Apr 27; 25():3100-3107. PubMed ID: 31028241
    [Abstract] [Full Text] [Related]

  • 5. Myocardial transfection of hypoxia-inducible factor-1α and co-transplantation of mesenchymal stem cells enhance cardiac repair in rats with experimental myocardial infarction.
    Huang B, Qian J, Ma J, Huang Z, Shen Y, Chen X, Sun A, Ge J, Chen H.
    Stem Cell Res Ther; 2014 Feb 07; 5(1):22. PubMed ID: 24507665
    [Abstract] [Full Text] [Related]

  • 6. Sevoflurane preconditioning alleviates myocardial ischemia reperfusion injury through mitochondrial NAD+-SIRT3 pathway in rats.
    Qin X, Qin Q, Ran K, Yuan G, Chang Y, Wang Y, Xiao Y.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Aug 28; 47(8):1108-1119. PubMed ID: 36097779
    [Abstract] [Full Text] [Related]

  • 7. Preconditioning of umbilical cord-derived mesenchymal stem cells by rapamycin increases cell migration and ameliorates liver ischaemia/reperfusion injury in mice via the CXCR4/CXCL12 axis.
    Zheng J, Li H, He L, Huang Y, Cai J, Chen L, Zhou C, Fu H, Lu T, Zhang Y, Yao J, Yang Y.
    Cell Prolif; 2019 Mar 28; 52(2):e12546. PubMed ID: 30537044
    [Abstract] [Full Text] [Related]

  • 8. Hypoxia pretreatment improves the therapeutic potential of bone marrow mesenchymal stem cells in hindlimb ischemia via upregulation of NRG-1.
    Peng X, Liang B, Wang H, Hou J, Yuan Q.
    Cell Tissue Res; 2022 Apr 28; 388(1):105-116. PubMed ID: 35091805
    [Abstract] [Full Text] [Related]

  • 9. Hypoxia-preconditioned mesenchymal stem cells prevent renal fibrosis and inflammation in ischemia-reperfusion rats.
    Ishiuchi N, Nakashima A, Doi S, Yoshida K, Maeda S, Kanai R, Yamada Y, Ike T, Doi T, Kato Y, Masaki T.
    Stem Cell Res Ther; 2020 Mar 20; 11(1):130. PubMed ID: 32197638
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. LncRNA SNHG1 alleviates hypoxia-reoxygenation-induced vascular endothelial cell injury as a competing endogenous RNA through the HIF-1α/VEGF signal pathway.
    Liang S, Ren K, Li B, Li F, Liang Z, Hu J, Xu B, Zhang A.
    Mol Cell Biochem; 2020 Feb 20; 465(1-2):1-11. PubMed ID: 31792649
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hypoxia pretreatment of bone marrow mesenchymal stem cells facilitates angiogenesis by improving the function of endothelial cells in diabetic rats with lower ischemia.
    Liu J, Hao H, Xia L, Ti D, Huang H, Dong L, Tong C, Hou Q, Zhao Y, Liu H, Fu X, Han W.
    PLoS One; 2015 Feb 20; 10(5):e0126715. PubMed ID: 25996677
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hypoxic preconditioning improves the survival and neural effects of transplanted mesenchymal stem cells via CXCL12/CXCR4 signalling in a rat model of cerebral infarction.
    Hu Y, Chen W, Wu L, Jiang L, Qin H, Tang N.
    Cell Biochem Funct; 2019 Oct 20; 37(7):504-515. PubMed ID: 31368195
    [Abstract] [Full Text] [Related]

  • 16. Mesenchymal stem cells preconditioned with trimetazidine promote neovascularization of hearts under hypoxia/reoxygenation injury.
    Hu X, Yang J, Wang Y, Zhang Y, Ii M, Shen Z, Hui J.
    Int J Clin Exp Med; 2015 Oct 20; 8(9):16991-7005. PubMed ID: 26629255
    [Abstract] [Full Text] [Related]

  • 17. VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function.
    Markel TA, Wang Y, Herrmann JL, Crisostomo PR, Wang M, Novotny NM, Herring CM, Tan J, Lahm T, Meldrum DR.
    Am J Physiol Heart Circ Physiol; 2008 Dec 20; 295(6):H2308-14. PubMed ID: 18849336
    [Abstract] [Full Text] [Related]

  • 18. Cellular repressor of E1A-stimulated gene overexpression in bone mesenchymal stem cells protects against rat myocardial infarction.
    Peng C, Pei H, Wei F, Tian X, Deng J, Yan C, Li Y, Sun M, Zhang J, Liu D, Rong J, Wang J, Gao E, Li S, Han Y.
    Int J Cardiol; 2015 Mar 15; 183():232-41. PubMed ID: 25679992
    [Abstract] [Full Text] [Related]

  • 19. Intravenous Anesthetics Enhance the Ability of Human Bone Marrow-Derived Mesenchymal Stem Cells to Alleviate Hepatic Ischemia-Reperfusion Injury in a Receptor-Dependent Manner.
    Feng J, Yao W, Zhang Y, Xiang AP, Yuan D, Hei Z.
    Cell Physiol Biochem; 2018 Mar 15; 47(2):556-566. PubMed ID: 29794450
    [Abstract] [Full Text] [Related]

  • 20. Bone marrow-derived mesenchymal stem cells induced by inflammatory cytokines produce angiogenetic factors and promote prostate cancer growth.
    Yang KQ, Liu Y, Huang QH, Mo N, Zhang QY, Meng QG, Cheng JW.
    BMC Cancer; 2017 Dec 21; 17(1):878. PubMed ID: 29268703
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.